Kimia Therapeutics is a Berkeley-based biotech building ATLAS, a drug-discovery platform that pairs nanoliter-scale high-throughput precision chemistry with machine learning and genome editing to map the druggable space at single-atom resolution. Spun out of Carmot Therapeutics in 2023 and backed by $55M in Series A funding, Kimia is using its chemical atlas to advance therapeutic programs in cancer and immunology.
Clarify Health Solutions is a San Francisco-based healthcare analytics company that maps hundreds of millions of patient journeys through its cloud-based Atlas Platform, helping payers, providers, and life sciences companies make smarter decisions about cost, care, and outcomes in the shift to value-based care.